Çocuklarda Akut ve Kronik Ürtiker

Yakup Canıtez; Şükrü Çekiç

Review

Çocuklarda Akut ve Kronik Ürtiker

Year 2020, Volume: 12 Issue: 2, 127 - 132, 01.04.2020

Yakup Canıtez Şükrü Çekiç

Abstract

Ürtiker; sınırları belirgin, hızlı ortaya çıkan, kaşıntılı, basmakla solan, kızarıklık
(eritem) ve kabarıklıkla karakterize deri döküntüsüdür. Genellikle bir ürtiker plağı
24 saat içinde kaybolur. Her 5 insandan birinde hayatların boyunca en az bir kez ürtiker
atağı gelişmektedir. Kronik ürtiker akut ürtikere göre daha nadir görülmektedir.
Ürtiker tek başına lokal yakınmalara neden olurken, anafilaksi gibi hayatı tehdit
eden bir reaksiyonun belirtisi de olabilir. Bu nedenle her ürtiker olgusu dikkatle
değerlendirilmelidir. Ürtikerde altta yatan neden ve yapılacak tetkikler hastanın
anamnezi ve klinik verileri doğrultusunda yapılmalıdır. Tedavide en önemli basamak
tetikleyicilerden kaçınmak ve antihistaminik ilaçların kullanımıdır.

Keywords

ürtiker, çocuk, antihistaminik ilaçlar, anafilaksi

References

1. Tsakok T, Du Toit G, Flohr C. Pediatric Urticaria. Immunol Allergy Clin North Am 2014;34(1):117–39.
2. Tamay Z. Ürtiker Anjiyoödem. In: Şekerel BE, editor. Çocukluk Çağında Astım Alerji İmmünoloji. 2015. p. 523–31.
3. Zuberbier T, Aberer W, Asero R, Abdul Latiff AH, Baker D, et al. The EAACI/GA²LEN/EDF/WAO guideline for the definition,
classification, diagnosis and management of urticaria. Allergy. 2018 Jul;73(7):1393-1414.
4. Kocatürk Goncü E, Aktan S, Atakan N, Bülbül Baskan E, Erdem T, Koca R, et al. The Turkish guideline for the diagnosis
and management of urticaria-2016. Turkderm e Arch Turk Dermatol Venerol 2016;50:82e98.
5. Fraser K, Robertson L. Chronic urticaria and autoimmunity. Skin Therapy Lett. 2013;18(7):5-9.
6. Sarbjit S. Saini. Urticaria and Angioedema. In: Adkinson, N. Franklin, MD; Bochner, Bruce S., MD; Burks, A. Wesley, MD; Busse, William W., MD; Holgate, Stephen T., MD, DSc, FMedSci;
Lemanske, Robert F., MD; O’Hehir, Robyn E., FRACP, PhD Frcp, editor. Middleton’s Allergy: Principles and Practice 2014. p. 575–87.
7. Stull D, McBride D, Georgiou P, Zuberbier T, Grattan C, Balp M-M: Measuring patient severity in chronic spontaneous/idiopathic
urticaria (CSU/CIU) as categorical health states: efficient and informative? Allergy 2014;69(suppl 99):317.
8. Grattan CE. Aspirin sensitivity and urticaria. Clin Exp Dermatol 2003;28:123-7.
9. Asero R. New-onset urticaria. https://www.uptodate.com/contents/ new-onset-urticaria.
10. Cavkaytar O, Arik Yilmaz E, Buyuktiryaki B, Sekerel BE, Sackesen C, Soyer OU. Challenge-proven aspirin hypersensitivity
in children with chronic spontaneous urticaria. Allergy. 2015 Feb;70(2):153-60.
11. Harmancı K, Arga M, Uysal P, Asilsoy S, Çetinkaya F et al. Turkish National Society of Allergy and Clinical Immunology
Position Paper: Diagnosis and Management of Urticaria. Asthma Allergy Immunol 2018; 16:Supplement: 2, 97-122.
12. Simons FE, Simons KJ. Histamine and H1-antihistamines: celebrating a century of progress. J Allergy Clin Immunol. 2011;128(6):1139-1150.
13. Powell RJ, Leech SC, Till S, Huber PA, Nasser SM, Clark AT; British Society for Allergy and Clinical Immunology. BSACI
guideline for the management of chronic urticaria and angioedema. Clin Exp Allergy. 2015 Mar;45(3):547-65.
14. Bernstein JA, Lang DM, Khan DA, Craig T, Dreyfus D, et al. The diagnosis and management of acute and chronic urticaria:
2014 update. J Allergy Clin Immunol. 2014 May;133(5):1270-7.
15. Omalizumab (Xolair): Treatment of Adults and Adolescents (12 Years of Age and above) with Chronic Idiopathic Urticaria
[Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2015 Aug. Available from http://www.ncbi.nlm.nih.gov/books/NBK3 62676/

Year 2020, Volume: 12 Issue: 2, 127 - 132, 01.04.2020

Yakup Canıtez Şükrü Çekiç

Abstract

References

1. Tsakok T, Du Toit G, Flohr C. Pediatric Urticaria. Immunol Allergy Clin North Am 2014;34(1):117–39.
2. Tamay Z. Ürtiker Anjiyoödem. In: Şekerel BE, editor. Çocukluk Çağında Astım Alerji İmmünoloji. 2015. p. 523–31.
3. Zuberbier T, Aberer W, Asero R, Abdul Latiff AH, Baker D, et al. The EAACI/GA²LEN/EDF/WAO guideline for the definition,
classification, diagnosis and management of urticaria. Allergy. 2018 Jul;73(7):1393-1414.
4. Kocatürk Goncü E, Aktan S, Atakan N, Bülbül Baskan E, Erdem T, Koca R, et al. The Turkish guideline for the diagnosis
and management of urticaria-2016. Turkderm e Arch Turk Dermatol Venerol 2016;50:82e98.
5. Fraser K, Robertson L. Chronic urticaria and autoimmunity. Skin Therapy Lett. 2013;18(7):5-9.
6. Sarbjit S. Saini. Urticaria and Angioedema. In: Adkinson, N. Franklin, MD; Bochner, Bruce S., MD; Burks, A. Wesley, MD; Busse, William W., MD; Holgate, Stephen T., MD, DSc, FMedSci;
Lemanske, Robert F., MD; O’Hehir, Robyn E., FRACP, PhD Frcp, editor. Middleton’s Allergy: Principles and Practice 2014. p. 575–87.
7. Stull D, McBride D, Georgiou P, Zuberbier T, Grattan C, Balp M-M: Measuring patient severity in chronic spontaneous/idiopathic
urticaria (CSU/CIU) as categorical health states: efficient and informative? Allergy 2014;69(suppl 99):317.
8. Grattan CE. Aspirin sensitivity and urticaria. Clin Exp Dermatol 2003;28:123-7.
9. Asero R. New-onset urticaria. https://www.uptodate.com/contents/ new-onset-urticaria.
10. Cavkaytar O, Arik Yilmaz E, Buyuktiryaki B, Sekerel BE, Sackesen C, Soyer OU. Challenge-proven aspirin hypersensitivity
in children with chronic spontaneous urticaria. Allergy. 2015 Feb;70(2):153-60.
11. Harmancı K, Arga M, Uysal P, Asilsoy S, Çetinkaya F et al. Turkish National Society of Allergy and Clinical Immunology
Position Paper: Diagnosis and Management of Urticaria. Asthma Allergy Immunol 2018; 16:Supplement: 2, 97-122.
12. Simons FE, Simons KJ. Histamine and H1-antihistamines: celebrating a century of progress. J Allergy Clin Immunol. 2011;128(6):1139-1150.
13. Powell RJ, Leech SC, Till S, Huber PA, Nasser SM, Clark AT; British Society for Allergy and Clinical Immunology. BSACI
guideline for the management of chronic urticaria and angioedema. Clin Exp Allergy. 2015 Mar;45(3):547-65.
14. Bernstein JA, Lang DM, Khan DA, Craig T, Dreyfus D, et al. The diagnosis and management of acute and chronic urticaria:
2014 update. J Allergy Clin Immunol. 2014 May;133(5):1270-7.
15. Omalizumab (Xolair): Treatment of Adults and Adolescents (12 Years of Age and above) with Chronic Idiopathic Urticaria
[Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2015 Aug. Available from http://www.ncbi.nlm.nih.gov/books/NBK3 62676/

There are 24 citations in total.

Details

Primary Language	Turkish
Subjects	Internal Diseases
Journal Section	makale
Authors	Yakup Canıtez This is me Şükrü Çekiç This is me
Publication Date	April 1, 2020
Published in Issue	Year 2020 Volume: 12 Issue: 2

Cite

APA	Canıtez, Y., & Çekiç, Ş. (2020). Çocuklarda Akut ve Kronik Ürtiker. Klinik Tıp Pediatri Dergisi, 12(2), 127-132.
AMA	Canıtez Y, Çekiç Ş. Çocuklarda Akut ve Kronik Ürtiker. Pediatri. April 2020;12(2):127-132.
Chicago	Canıtez, Yakup, and Şükrü Çekiç. “Çocuklarda Akut Ve Kronik Ürtiker”. Klinik Tıp Pediatri Dergisi 12, no. 2 (April 2020): 127-32.
EndNote	Canıtez Y, Çekiç Ş (April 1, 2020) Çocuklarda Akut ve Kronik Ürtiker. Klinik Tıp Pediatri Dergisi 12 2 127–132.
IEEE	Y. Canıtez and Ş. Çekiç, “Çocuklarda Akut ve Kronik Ürtiker”, Pediatri, vol. 12, no. 2, pp. 127–132, 2020.
ISNAD	Canıtez, Yakup - Çekiç, Şükrü. “Çocuklarda Akut Ve Kronik Ürtiker”. Klinik Tıp Pediatri Dergisi 12/2 (April 2020), 127-132.
JAMA	Canıtez Y, Çekiç Ş. Çocuklarda Akut ve Kronik Ürtiker. Pediatri. 2020;12:127–132.
MLA	Canıtez, Yakup and Şükrü Çekiç. “Çocuklarda Akut Ve Kronik Ürtiker”. Klinik Tıp Pediatri Dergisi, vol. 12, no. 2, 2020, pp. 127-32.
Vancouver	Canıtez Y, Çekiç Ş. Çocuklarda Akut ve Kronik Ürtiker. Pediatri. 2020;12(2):127-32.

Download Cover Image

Article Files

Full Text